Harbin Gloria Pharmaceuticals (002437) — Capital Reinvestment Ratio
Harbin Gloria Pharmaceuticals (002437) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥182.89 Million) in capital expenditures (CN¥4.26 Million). See Harbin Gloria Pharmaceuticals (002437) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Harbin Gloria Pharmaceuticals Capital Reinvestment Ratio (2007–2025)
This chart tracks Harbin Gloria Pharmaceuticals's Capital Reinvestment Ratio across 19 annual periods. Check Harbin Gloria Pharmaceuticals (002437) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Harbin Gloria Pharmaceuticals (2007–2025)
Year-by-year Capital Reinvestment Ratio for Harbin Gloria Pharmaceuticals from 2007 to 2025. For live market cap and broader valuation context, see Harbin Gloria Pharmaceuticals stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥273.36 Million | CN¥23.81 Million | ▼ -43.1% |
| 2024 | 0.15x | CN¥410.94 Million | CN¥62.90 Million | ▲ +41.7% |
| 2023 | 0.11x | CN¥274.18 Million | CN¥29.62 Million | ▼ -14.4% |
| 2022 | 0.13x | CN¥261.62 Million | CN¥33.01 Million | ▲ +0.3% |
| 2021 | 0.13x | CN¥274.18 Million | CN¥34.51 Million | ▼ -96.3% |
| 2020 | 3.42x | CN¥12.76 Million | CN¥43.66 Million | ▲ +4211.5% |
| 2019 | 0.08x | CN¥610.37 Million | CN¥48.43 Million | ▼ -11.6% |
| 2018 | 0.09x | CN¥1.16 Billion | CN¥104.34 Million | ▼ -69.9% |
| 2017 | 0.30x | CN¥651.80 Million | CN¥194.63 Million | ▲ +67.6% |
| 2016 | 0.18x | CN¥1.04 Billion | CN¥185.34 Million | ▼ -55.8% |
| 2015 | 0.40x | CN¥702.05 Million | CN¥283.10 Million | ▲ +115.9% |
| 2014 | 0.19x | CN¥674.04 Million | CN¥125.89 Million | ▼ -48.2% |
| 2013 | 0.36x | CN¥453.02 Million | CN¥163.35 Million | ▼ -48.6% |
| 2012 | 0.70x | CN¥205.89 Million | CN¥144.37 Million | ▼ -46.0% |
| 2011 | 1.30x | CN¥128.61 Million | CN¥166.90 Million | ▼ -39.3% |
| 2010 | 2.14x | CN¥112.59 Million | CN¥240.88 Million | ▲ +494.5% |
| 2009 | 0.36x | CN¥170.82 Million | CN¥61.47 Million | ▼ -45.4% |
| 2008 | 0.66x | CN¥57.81 Million | CN¥38.08 Million | ▲ +161.3% |
| 2007 | 0.25x | CN¥52.26 Million | CN¥13.17 Million | — |